NCT06821399Recruiting
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
This study aims to integrate clinical indicators and features of fundus images, combined with metabolomics, to construct an early warning model for diabetic retinopathy (DR) in type 2 diabetes. By combining clinical indicators with metabolomics, the investigators aim to establish a precise DR typing model based on the age of diabetes onset (early-onset diabetes, late-onset diabetes) and based on the coexistence with two types of diabetic macrovascular complications. A multidisciplinary collaboration will be conducted for comprehensive management of DR to control the progression of moderate-stage DR. Cloud-based patient rooms combined with continuous glucose monitoring (CGM) will further explore the role of integrated diabetes retinopathy ward management models in the management of patients undergoing diabetes retinopathy surgery, pioneering a new model for the management of advanced DR.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2920 (estimated)
- First submitted
- 2 Jan 2025
- Start date
- 1 Feb 2025
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- Yufan Wang
- Diseases
- Type 2 diabetes, Diabetic eye disease
- NCT number
- NCT06821399
What you commit to
- Study type: Observational
- Planned participants: 2920
- From 1 Feb 2025 to the primary completion date, 31 Aug 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Those who have been diagnosed with type 1 or other types of diabetes;
- Those with severe cardiac, pulmonary, hepatic, or renal insufficiency;
- Those with mental confusion, speech disorders, or dementia, etc.;
- Those who are unable to take care of themselves, bedridden, or have mobility impairments; ⑤ Women who are breastfeeding or pregnant;
- Those with a recent history of surgery, trauma, acute major vascular complications, or infectious diseases.
Who the study is looking for
- Meets the diagnostic criteria for type 2 diabetes in the "China Type 2 Diabetes Prevention and Treatment Guidelines (2020 Edition)";
- Aged between 20 and 79 years old, without other severe underlying diseases; ③ Possesses full cognitive and literacy abilities; ④ Volunteers to participate in this study and are willing to sign an informed consent form.
Age in the registry: 20 years to 79 years · Sex: All
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The first hosptial of lanzhou university Coordinator of this site? Confirm its status | Lanzhou | China | Recruiting |
| Shanghai general hosptial Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
| The forth people's hosptial of shenyang Coordinator of this site? Confirm its status | Shenyang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.